ArticleScientific reports2025
DSSCC net enhanced skin cancer classification using SMOTE Tomek and optimized convolutional neural network.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin cancer remains a major global health concern where early detection can significantly improve treatment outcomes. Traditional methods rely on expert evaluation, which can be prone to errors. DSSCC-Net, a deep CNN model integrated with SMOTE-Tomek oversampling, improves classification accuracy and effectively handles class imbalance in dermoscopic datasets. Trained and validated on the HAM10000, ISIC 2018 and PH2 datasets, DSSCC-Net achieved an average accuracy of 97.82% ± 0.37%, precision of 97%, recall of 97% and an AUC of 99.43%. Additional analysis using Grad-CAM and expert-labeled masks validated the model's explainability. DSSCC-Net demonstrates state-of-the-art performance and readiness for real-world clinical integration. Current CNN-based models struggle with accurately classifying underrepresented skin lesion classes due to dataset imbalances and fail to achieve consistently high performance across diverse populations. There is a pressing need for a robust, efficient, and interpretable model to aid dermatologists in early and accurate diagnosis. This study proposes DSSCC-Net, a novel deep learning framework that integrates an optimized CNN architecture with the SMOTE-Tomek technique to address class imbalance. The model processes dermoscopic images from the HAM10000 dataset, resized to 28×28 pixels, and employs data augmentation, dropout layers, and ReLU activation to enhance feature extraction and reduce overfitting. Performance is evaluated using metrics such as accuracy, precision, recall, F1-score, and AUC, alongside Grad-CAM for interpretability. DSSCC-Net achieves a 98% classification accuracy, outperforming state-of-the-art models like VGG-16 (91.12%), ResNet-152 (89.32%), and EfficientNet-B0 (89.46%). The SMOTE-Tomek integration significantly improves minority-class detection, yielding an AUC of 99.43%. The model also demonstrates balanced precision (97%) and recall (97%), with a low loss value (0.1677), indicating strong generalization. DSSCC-Net sets a new benchmark for skin cancer classification by effectively addressing class imbalance and computational limitations. Its high interpretability, achieved through Grad-CAM, makes it a practical tool for clinical deployment. Future work includes extending this framework to other medical imaging domains and developing real-time diagnostic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.